We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

48 hedge funds and large institutions have $18.8M invested in AVEO Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $108K | Put options by funds: $54K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less funds holding

Funds holding: 54 → 48 (-6)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

36% less capital invested

Capital invested by funds: $29.6M → $18.8M (-$10.8M)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
48
Holders Change
-6
Holders Change %
-11.11%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
1
Increased
11
Reduced
16
Closed
7
Calls
$108K
Puts
$54K
Net Calls
+$54K
Net Calls Change
+$46K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$144K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$76K
3
RCM
Rotella Capital Management
Washington
+$15.2K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$14.5K
5
UBS Group
UBS Group
Switzerland
+$12.9K

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$1.04M
2
BIT
BlackRock Institutional Trust
California
-$469K
3
SIM
Spark Investment Management
New York
-$211K
4
Creative Planning
Creative Planning
Kansas
-$167K
5
Two Sigma Investments
Two Sigma Investments
New York
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$2.8M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.69M +$144K +9,931 +5%
Renaissance Technologies
3
Renaissance Technologies
New York
$2.53M -$41.9K -2,900 -1%
BIT
4
BlackRock Institutional Trust
California
$2.35M -$469K -32,481 -14%
CAM
5
Cormorant Asset Management
Massachusetts
$1.92M – – –
GCM
6
Gruss Capital Management
New York
$1.89M – – –
DVC
7
Deer VI & Co
New York
$817K – – –
GIM
8
Granahan Investment Management
Massachusetts
$794K -$40.6K -2,810 -4%
GX
9
Greylock XI
Massachusetts
$707K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$345K -$141K -9,729 -25%
BCM
11
Bridgeway Capital Management
Texas
$235K – – –
USAA
12
United Services Automobile Association
Texas
$191K -$40.6K -2,810 -15%
BFA
13
BlackRock Fund Advisors
California
$163K -$5.14K -356 -3%
CC
14
Cannell & Co
New York
$154K – – –
TC
15
TFS Capital
Pennsylvania
$135K -$83.3K -5,766 -34%
FM
16
Family Management
New York
$121K – – –
Morgan Stanley
17
Morgan Stanley
New York
$116K -$145K -10,001 -51%
Tudor Investment Corp
18
Tudor Investment Corp
Connecticut
$101K +$2.28K +158 +2%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$93K -$14 -1 -0%
Goldman Sachs
20
Goldman Sachs
New York
$91K +$8.61K +596 +9%
Northern Trust
21
Northern Trust
Illinois
$89K +$1.91K +132 +2%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$83K +$76K +5,259 +336%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$55K +$14.5K +1,000 +28%
EWM
24
Evercore Wealth Management
New York
$47K – – –
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$40K – – –
1
2 3

AVEO Hedge Fund Activity: Q3 2015 in Review

48 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q3 2015, worth a combined $18.8M — down 36% from $29.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AVEO and 1 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, adding an estimated $144K. The largest seller was PointState Capital, exiting entirely with an estimated $1.04M sold.

  • 48 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q3 2015, down from 54 in Q2 2015.
  • Funds reported $18.8M of AVEO Pharmaceuticals, Inc. stock for Q3 2015, down 36% quarter-over-quarter.
  • 1 fund opened new AVEO Pharmaceuticals, Inc. positions in Q3 2015 and 7 closed out, a net change of -6 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q3 2015 was Vanguard Group, an estimated $144K added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q3 2015 was PointState Capital, an estimated $1.04M sold.

Based on aggregated 13F filings for Q3 2015.